Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ross

Showing results (441-450 of 587) with videos related to

Pageof 59
Sort By:
Annals of Surgical Oncology|May 26, 2026
The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with MicrosatellitosisAnjali Devireddy, Yifan Yi, Kelsey N Nordlund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemC M Balch, S J Soong, J E Gershenwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Final version of the American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, S J Soong, et al.
CA: a Cancer Journal for Clinicians|June 16, 2004
An evidence-based staging system for cutaneous melanomaCharles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node BiopsyKelly M McMasters, Michael E Egger, Michael J Edwards, et al.
Cancer|March 16, 2000
A new American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, M B Atkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapyRichard W Joseph, Vijay R Peddareddigari, Ping Liu, et al.
Cancer|January 11, 2005
Breast conservation after neoadjuvant chemotherapyAllen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.
Seminars in Surgical Oncology|August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Circulating Tumor Cells and Early Relapse in Node-positive MelanomaAnthony Lucci, Carolyn S Hall, Sapna P Patel, et al.
Pageof 59

Showing results (441-450 of 587) with videos related to

Sort By:
Pageof 59
Annals of Surgical Oncology|May 26, 2026
The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with MicrosatellitosisAnjali Devireddy, Yifan Yi, Kelsey N Nordlund, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemC M Balch, S J Soong, J E Gershenwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Final version of the American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, S J Soong, et al.
CA: a Cancer Journal for Clinicians|June 16, 2004
An evidence-based staging system for cutaneous melanomaCharles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node BiopsyKelly M McMasters, Michael E Egger, Michael J Edwards, et al.
Cancer|March 16, 2000
A new American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, M B Atkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapyRichard W Joseph, Vijay R Peddareddigari, Ping Liu, et al.
Cancer|January 11, 2005
Breast conservation after neoadjuvant chemotherapyAllen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.
Seminars in Surgical Oncology|August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Circulating Tumor Cells and Early Relapse in Node-positive MelanomaAnthony Lucci, Carolyn S Hall, Sapna P Patel, et al.
Pageof 59